Copy
View this email in your browser

Professor Nicholas Huntington

NHMRC Leadership Fellow & Head Cancer Immunotherapy Laboratory, Monash Biomedicine Discovery Institute

"Targeting Natural Killer cells in cancer immunotherapy"

Prof Huntington will present recent clinical evidence that natural killer (NK) cells are a key in the protective anti-tumour immune response and discuss new opportunities to target NK cell function to enhance cancer immunotherapy response rates across a more diverse range of cancers.

Friday 27 May 2022
2pm to 3pm

Register for this seminar
Monash Partners Comprehensive Cancer Consortium (MPCCC) is a strategic alliance of health service and research organisations working in partnership to improve cancer outcomes through integrated, collaborative and innovative research and clinical care programs.
Twitter
Website
LinkedIn
Copyright © 2022 MPCCC, All rights reserved.


Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.

Email Marketing Powered by Mailchimp